Suppr超能文献

miR-199a-5p 通过靶向脑缺血后 Cav-1 增强神经干细胞的神经元分化并促进神经发生。

MiR-199a-5p enhances neuronal differentiation of neural stem cells and promotes neurogenesis by targeting Cav-1 after cerebral ischemia.

机构信息

Department of Physiology, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

CNS Neurosci Ther. 2023 Dec;29(12):3967-3979. doi: 10.1111/cns.14323. Epub 2023 Jun 22.

Abstract

AIMS

MicroRNAs (miRs) are involved in endogenous neurogenesis, enhancing of which has been regarded as a potential therapeutic strategy for ischemic stroke treatment; however, whether miR-199a-5p mediates postischemic neurogenesis remains unclear. This study aims to investigate the proneurogenesis effects of miR-199a-5p and its possible mechanism after ischemic stroke.

METHODS

Neural stem cells (NSCs) were transfected using Lipofectamine 3000 reagent, and the differentiation of NSCs was evaluated by immunofluorescence and Western blotting. Dual-luciferase reporter assay was performed to verify the target gene of miR-199a-5p. MiR-199a-5p agomir/antagomir were injected intracerebroventricularly. The sensorimotor functions were evaluated by neurobehavioral tests, infarct volume was measured by toluidine blue staining, neurogenesis was detected by immunofluorescence assay, and the protein levels of neuronal nuclei (NeuN), glial fibrillary acidic protein (GFAP), caveolin-1 (Cav-1), vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) were measured by Western blotting.

RESULTS

MiR-199a-5p mimic enhanced neuronal differentiation and inhibited astrocyte differentiation of NSCs, while a miR-199a-5p inhibitor induced the opposite effects, which can be reversed by Cav-1 siRNA. Cav-1 was through the dual-luciferase reporter assay confirmed as a target gene of miR-199a-5p. miR-199a-5p agomir in rat stroke models manifested multiple benefits, such as improving neurological deficits, reducing infarct volume, promoting neurogenesis, inhibiting Cav-1, and increasing VEGF and BDNF, which was reversed by the miR-199a-5p antagomir.

CONCLUSION

MiR-199a-5p may target and inhibit Cav-1 to enhance neurogenesis and thus promote functional recovery after cerebral ischemia. These findings indicate that miR-199a-5p is a promising target for the treatment of ischemic stroke.

摘要

目的

微小 RNA(miRs)参与内源性神经发生,增强其活性被认为是治疗缺血性中风的潜在治疗策略;然而,miR-199a-5p 是否介导缺血后神经发生尚不清楚。本研究旨在探讨 miR-199a-5p 的促神经发生作用及其在缺血性中风后的可能机制。

方法

采用 Lipofectamine 3000 试剂转染神经干细胞(NSCs),通过免疫荧光和 Western blot 评估 NSCs 的分化情况。双荧光素酶报告实验验证 miR-199a-5p 的靶基因。通过脑室内注射 miR-199a-5p 激动剂/拮抗剂。采用神经行为学测试评估感觉运动功能,甲苯胺蓝染色测量梗死体积,免疫荧光检测神经发生,Western blot 检测神经元核(NeuN)、胶质纤维酸性蛋白(GFAP)、窖蛋白-1(Cav-1)、血管内皮生长因子(VEGF)和脑源性神经营养因子(BDNF)的蛋白水平。

结果

miR-199a-5p 模拟物增强了 NSCs 的神经元分化,抑制了星形胶质细胞分化,而 miR-199a-5p 抑制剂则诱导了相反的效果,这可以通过 Cav-1 siRNA 逆转。Cav-1 通过双荧光素酶报告实验证实是 miR-199a-5p 的靶基因。在大鼠中风模型中,miR-199a-5p 激动剂表现出多种益处,如改善神经功能缺损、减少梗死体积、促进神经发生、抑制 Cav-1、增加 VEGF 和 BDNF,这些益处可被 miR-199a-5p 拮抗剂逆转。

结论

miR-199a-5p 可能靶向并抑制 Cav-1 以增强神经发生,从而促进脑缺血后的功能恢复。这些发现表明 miR-199a-5p 是治疗缺血性中风的有前途的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9483/10651989/aca121c2c754/CNS-29-3967-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验